Vertex Pharmaceuticals Inc / Ma (VRTX)
- Sector
- Health Care
- Industry
- Biotechnology
- Last price
- $529.69
- As of
Kresmion compiles this page from VRTX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
VERTEX PHARMACEUTICALS INC / MA (VRTX): 7 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-20.
See the full VRTX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for VRTX on one page. Preview it with sample data, then open it live with a free account.
Preview the VRTX dossierActive events for VRTX
- high13F: funds reduced
3 tracked funds reduced VRTX this 2026Q2, institutional consensus
- high13F: funds added
5 tracked funds increased VRTX this 2026Q2, institutional consensus
- high13F: large increase
CITADEL ADVISORS LLC added +114% to VRTX (2026Q2)
- high13F: large increase
CITADEL ADVISORS LLC added +346% to VRTX (2026Q2)
- high13F: large reduction
Point72 Asset Management, L.P. cut 56% of VRTX (2026Q2)
FREE, NO ACCOUNT
Every event on VRTX, as it fires
You are seeing 5 of 46 events recorded on VRTX since 2026-05-05.
The five above landed across 2 days. The other 41 were recorded on 3 other days. 34 of the 46 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in VRTX (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLCCUSIP 92532F100 · 2026Q2 | $253.5M | 0.03% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 92532F100 · 2026Q2 | $232.7M | 0.08% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 92532F100 · 2026Q2 | $159M | 0.22% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 92532F100 · 2026Q2 | $141.6M | 0.10% | , |
| Bridgewater Associates, LPCUSIP 92532F100 · 2026Q2 | $5.4M | 0.02% | , |
| D. E. Shaw & Co., Inc.CUSIP 92532F100 · 2026Q2 | $1.5M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 92532F100 · 2026Q2 | $1.3M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, VRTX
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
Follow VRTX on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to VRTX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.